Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
Alternative Therapies in Health and Medicine, 2025
Published: 11/11/2025
Summary
This pilot study on intravenous BPC-157 in humans found it to be safe and well tolerated. Credible early evidence but limited by small sample size and lack of replication.
Details
A small-scale pilot study assessing the safety and tolerability of intravenous BPC-157. Results show it is well tolerated in humans under controlled settings, though larger clinical trials are needed.
Research Quality Score
Assessment
The study provides preliminary safety data on BPC-157, which is valuable for future research. However, its small scale and pilot nature limit the strength of its conclusions. Methodological rigor is adequate for a pilot study, but further research with larger sample sizes and more robust designs is needed.
Category Breakdown
| Category | Score | Max Points | Weight |
|---|---|---|---|
| Study Design / Evidence Level | 2 | 3 | 20% |
| Bias & Methods | 1.5 | 3 | 25% |
| Statistical Integrity | 1 | 2 | 15% |
| Transparency | 1.5 | 2 | 10% |
| Conflict of Interest Disclosure | 2 | 2 | 10% |
| Replication / External Validation | 0 | 1 | 5% |
| Relevance | 1 | 1 | 5% |
| Journal Quality | 1.5 | 2 | 10% |
Additional Notes
The study is a useful starting point for further investigation into BPC-157, but its findings should be interpreted with caution due to the limited sample size and lack of replication.